Compositions and methods for succinate production

US11390873B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11390873-B2
Application numberUS-201615386506-A
CountryUS
Kind codeB2
Filing dateDec 21, 2016
Priority dateJan 25, 2011
Publication dateJul 19, 2022
Grant dateJul 19, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing succinate comprising culturing genetically modified yeast cells in the presence of at least one carbon source and isolating succinate from the culture, wherein the genetically modified yeast cells are from the Pichia fermentans/Issatchenkia orientalis clade and have an active succinate fermentation pathway from phosphoenolpyruvate or pyruvate to succinate, wherein the active succinate fermentation pathway comprises the reactions: (a) pyruvate to oxaloacetate; (b) oxaloacetate to malate; (c) malate to fumarate; and (d) fumarate to succinate, wherein the cells comprise an exogenous succinate exporter gene that catalyzes export of succinate from inside the cell to the extracellular environment. 2. The method of claim 1 , wherein the cell comprises a further exogenous nucleic acid encoding an enzyme that catalyzes any one of reactions (a) to (d). 3. The method of claim 2 , wherein the cell comprises an exogenous nucleic acid encoding pyruvate carboxylase, malate dehydrogenase, fumarase, or fumarate reductase. 4. The method of claim 3 , wherein the cell comprises an exogenous nucleic acid encoding a pyruvate carboxylase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 8, 10, or 12. 5. The method of claim 3 , wherein the cell comprises an exogenous nucleic acid encoding a malate dehydrogenase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 14, 16, 18, 168, 20, 22, or 24. 6. The method of claim 3 , wherein the cell comprises an exogenous nucleic acid encoding a malate dehydrogenase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 170. 7. The method of claim 3 , wherein the cell comprises an exogenous nucleic acid encoding a fumarase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 2. 8. The method of claim 3 , wherein the cell comprises an exogenous nucleic acid encoding a fumarate reductase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 26, 28, 30, or 32. 9. The method of claim 3 , wherein the cell comprises an exogenous nucleic acid encoding a fumarate reductase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 174, 176, 178, or 180. 10. The method of claim 1 , wherein the cell comprises an exogenous succinate exporter gene encoding a polypeptide comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 182 or 184. 11. The method of claim 1 , wherein the active succinate fermentation pathway comprises the reaction phosphoenolpyruvate to oxaloacetate in addition to reaction (a). 12. The method of claim 11 , wherein the cell comprises an exogenous nucleic acid encoding phosphoenolpyruvate carboxylase. 13. The method of claim 12 , wherein the cell comprises an exogenous nucleic acid encoding a phosphoenolpyruvate carboxylase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 4 or 6. 14. The method of claim 1 , wherein the cell comprises a deletion or disruption of an endogenous malic enzyme gene. 15. The method of claim 1 , wherein the cell comprises a deletion or disruption of an endogenous pyruvate decarboxylase gene. 16. The method of claim 1 , wherein the cell comprises an exogenous nucleic acid encoding glucose 6-phosphate dehydrogenase. 17. The method of claim 16 , wherein the cell comprises an exogenous nucleic acid encoding a glucose 6-phosphate dehydrogenase comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 34. 18. The method of claim 1 , which produces succinate at a concentration of at least 20 g/L. 19. A method of producing succinate comprising culturing genetically modified yeast cells in the presence of at least one carbon source and isolating succinate from the culture, wherein the genetically modified yeast cells are from the species Issatchenkia orientalis, Pichia kudriavzevii, Candida kruzei , or Candida lambica and have an active succinate fermentation pathway from phosphoenolpyruvate or pyruvate to succinate, wherein the active succinate fermentation pathway comprises the reactions: (a) pyruvate to oxaloacetate; (b) oxaloacetate to malate; (c) malate to fumarate; and (d) fumarate to succinate, wherein the cells comprise an exogenous succinate exporter, gene that catalyzes export of succinate from inside the cell to the extracellular environment. 20. The method of claim 19 , which produces succinate at a concentration of at least 20 g/L.

Assignees

Inventors

Classifications

  • Pyruvate carboxylase (6.4.1.1) · CPC title

  • Ligases (6) · CPC title

  • Malate dehydrogenase (1.1.1.37) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • acting on the CH-CH group of donors (1.3) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11390873B2 cover?
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
Who is the assignee on this patent?
Cargill Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/815. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).